PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.47%
Revenue growth under 50% of QRVO's 29.35%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
13.31%
Gross profit growth under 50% of QRVO's 30.47%. Michael Burry would be concerned about a severe competitive disadvantage.
37.52%
EBIT growth below 50% of QRVO's 100.00%. Michael Burry would suspect deeper competitive or cost structure issues.
-6.84%
Negative operating income growth while QRVO is at 167.52%. Joel Greenblatt would press for urgent turnaround measures.
-4.70%
Negative net income growth while QRVO stands at 91.23%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.08%
Negative EPS growth while QRVO is at 83.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.45%
Negative diluted EPS growth while QRVO is at 91.42%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.54%
Reduced diluted shares while QRVO is at 0.51%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.31%
Dividend growth of 0.31% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
70.77%
OCF growth under 50% of QRVO's 2160.97%. Michael Burry might suspect questionable revenue recognition or rising costs.
77.99%
FCF growth under 50% of QRVO's 422.89%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
100.90%
10Y CAGR of 100.90% while QRVO is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
13.95%
5Y CAGR of 13.95% while QRVO is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-6.30%
Negative 3Y CAGR while QRVO stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
254.02%
OCF/share CAGR of 254.02% while QRVO is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
30.17%
OCF/share CAGR of 30.17% while QRVO is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-5.66%
Negative 3Y OCF/share CAGR while QRVO stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.73%
10Y net income/share CAGR of 120.73% while QRVO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
32.93%
Net income/share CAGR of 32.93% while QRVO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-20.90%
Negative 3Y CAGR while QRVO is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
51.69%
Equity/share CAGR of 51.69% while QRVO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
30.26%
Equity/share CAGR of 30.26% while QRVO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
19.84%
Equity/share CAGR of 19.84% while QRVO is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
1205.79%
Dividend/share CAGR of 1205.79% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
179.73%
Dividend/share CAGR of 179.73% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.68%
3Y dividend/share CAGR of 132.68% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
2.21%
AR growth of 2.21% while QRVO is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
0.35%
Inventory shrinking or stable vs. QRVO's 16.94%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.79%
Negative asset growth while QRVO invests at 7.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.48%
Under 50% of QRVO's 92.23%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.08%
We’re deleveraging while QRVO stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-5.40%
Our R&D shrinks while QRVO invests at 10.82%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.27%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.